Abbhi Sankesh 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Jul 16, 2020
Insider Transaction Report
Form 4
Abbhi Sankesh
Director
Transactions
- Purchase
Common Stock
2020-07-15$12.99/sh+46,779$607,659→ 2,164,530 total(indirect: By LLC)
Holdings
- 250,000(indirect: By LLC)
Warrant to Purchase Common Stock
Exercise: $15.00From: 2020-03-06Exp: 2023-03-06→ Common Stock (250,000 underlying) - 4,657
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.82 to $13.14, inclusive. The Reporting Person undertakes to provide to the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Abbhi Investments, LLC is the record owner of these securities. Mr. Sankesh Abbhi is the manager of Abbhi Investments, LLC and maintains sole voting and investment power with respect to common stock and warrants held by Abbhi Investments, LLC.
- [F3]Pursuant to the March 6, 2020 Securities Purchase Agreement between Abbhi Investments, LLC and the Issuer, for an aggregate purchase price of $10,000,000, Abbhi Investments, LLC received 1,250,000 shares of Common Stock and a Warrant for 250,000 shares of Common Stock with a purchase price per share of $15.00, and an expiration date of the third anniversary of the date of issuance.